Treatment of schizophrenia with a vasopressin analogue



	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted



	Email this article to a Colleague
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Add to My Articles & Searches
	Download to citation manager



	Citing Articles via HighWire
	Citing Articles via Google Scholar



	Articles by Iager, A. C.
	Articles by Karson, C. N.
	Search for Related Content



	PubMed Citation
	Articles by Iager, A. C.
	Articles by Karson, C. N.

Am J Psychiatry 1986; 143:375-377
Copyright © 1986 by American Psychiatric Association

REGULAR ARTICLES

Treatment of schizophrenia with a vasopressin analogue

AC Iager, DG Kirch, LB Bigelow and CN Karson

Ten patients with chronic schizophrenia completed a 3-month double- blind, placebo-controlled trial with a vasopressin analogue. Modest improvement occurred, but several patients also experienced significant fluid and electrolyte imbalance.

This article has been cited by other articles:

I. Elman, S. Lukas, S. E. Shoaf, D. Rott, C. Adler, and A. Breier
Effects of Acute Metabolic Stress on the Peripheral Vasopressinergic System in Schizophrenia
J Psychopharmacol, September 1, 2003; 17(3): 317 - 323.
[Abstract] [PDF]

Get information about faster international access.